Article ISI SCOPUS
VACCINE  (2015)

Safety and immunogenicity of an MF59 (R)-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age

Knuf, M; Leroux-Roels, G; Rumke H.C.; Abarca, K; Rivera, L.; Lattanzi, M; Pedotti, P; Arora, A; Kieninger-Baum, D; Della Cioppa, G

Keywords: A/H1N1; MF59; Paediatric; Pandemic influenza; Vaccine; Www.clinicaltrials.gov (NCT00971542)

Más información

Título según WOS: Safety and immunogenicity of an MF59 (R)-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
Título según SCOPUS: Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
Título de la Revista: VACCINE
Volumen: 33
Número: 1
Editorial: ELSEVIER SCI LTD
Fecha de publicación: 2015
Página de inicio: 174
Página final: 181
Idioma: English
DOI:

10.1016/j.vaccine.2014.10.085
Notas: ISI, SCOPUS